Allucent

Happy Thanksgiving from the A-Team! We're so grateful to our employees and clients who help us drive progress and give hope to patients in need. We hope your Thanksgiving is filled with gratitude, togetherness, and delicious food. #Allucent #BringNewTherapiesToLight #HappyThanksgiving #HolidaySeason #Gratitude

New and small to midsize biotechs struggle without the expertise of experienced professionals on their team. In this interview with BiotechTV, Katy Moore, PharmD, RPh, President of Clinical Pharmacology Modeling and Simulation, explained that partnering with Allucent gives our clients access to experts with decades of experience to ensure their success. Click?here (https://lnkd.in/gfTZHRnc)?to learn more about how you can partner with the A-Team.

Join the A-Team for an illuminating poster presentation, "Comparison of Common Methodologies for Accounting for IIV for Oral Bioavailability in the Absence of Intravenous Data." Allucent expert Alex MacDonald, PhD will be presenting the findings of his team, including Kai Bartlette, PhD and Soha Freidy, PharmD, RPh, at the upcoming Pharmacokinetics (U.K.) meeting. Learn more by connecting with our team on LinkedIn or visiting our website:?https://lnkd.in/ggFuZshF. #Allucent #BringNewTherapiesToLight #PKUK2024 #Pharmacokinetics #ClinicalPharmacology

Unlock the full potential of your clinical trial data. In our latest blog,?https://lnkd.in/gS9FUbRM,?Allucent expert Benoit Piavaux, PhD, reveals how combining graphical and tabular visualizations can help you gain deeper insights, identify critical trends, and make informed decisions faster. Discover how this approach ensures patient safety, minimizes delays, and drives the success needed to advance your trials. #Allucent #BringNewTherapiesToLight #DataScience #DataManagement #ClinicalResearch #PatientSafety #ClinicalDataScience

Project management plays a critical role in clinical trial success, ensuring every detail is managed with precision and proactive problem-solving. Today, we’re introducing a new series from our Project Management leadership, designed to share expert perspectives on navigating the complexities of this essential function and driving successful outcomes. Our first article,?“The Siren Song of Hope,” by Angela Brady, SVP, Project Leadership and Client Relations, explores why precision and actionable strategies—not hope—are essential in clinical trial project management. Follow along for more insights into the challenges and solutions that define effective trial management. #Allucent #BringNewTherapiesToLight #ProjectManagement #ProjectLeadership #ClinicalResearch

Data Monitoring Committees (DMCs) play a vital role in protecting patients and ensuring the success of clinical trials by providing objective, data-driven insights that support sound decision-making. For biotechs, leveraging a DMC can offer more than just an added layer of oversight—it’s a strategic tool to optimize trial outcomes and navigate complex regulatory landscapes. In this blog, our A-team experts, Vanessa Beddo, PhD, and Melanie Buitendyk, MSc, share key insights on how thoughtful DMC planning and execution can strengthen your trial’s success. Learn about the critical components of a DMC charter, the importance of unblinded data reviews, and how Allucent’s expertise can help you unlock the full potential of your DMC to achieve your development goals. Read the blog to explore their expert strategies and recommendations https://lnkd.in/gfqHWizD #Allucent #BringNewTherapiesToLight #DataMonitoringCommittee #Biostatistics #PatientSafety #ClinicalResearch

In this edition of our?A-Team Spotlight?series, we’re excited to introduce Dr. Benoit Piavaux, Ph.D.! With over 20 years of experience spanning fundamental medical, preclinical, and clinical research, Dr. Piavaux is a leader in clinical programming and data science. His expertise ensures high-quality data management, fostering collaboration among data science experts to drive risk mitigation and data-driven decision-making in clinical trials. Discover how Dr. Piavaux and the Allucent team optimize data insights to advance clinical development. Connect with him and explore our clinical programming and data science capabilities on our website. https://lnkd.in/gNiR8tsm #Allucent #BringNewTherapiesToLight #DataManagement #ClinicalProgramming #ClinicalDataScience #ClinicalDevelopment

Check out our recent podcast where industry experts Marcus Delatte, PhD and Harshini Neelakantan, Ph.D. review key considerations when preparing for pre-IND meetings and completing an IND application (?https://lnkd.in/g3NW5EV5). They go on to discuss a range of topics including the current landscape of INDs, the benefits and purpose of pre-IND meetings, common misconceptions, and essential strategies for preparing a successful IND application. #Allucent #BringNewTherapiesToLight #FDAApproval #RegulatorySubmissions #ClinicalResearch

Our A-Team of Experts is ending the year on a high note as they head to the ASH Annual Meeting in San Diego!??Schedule a meeting now:?https://lnkd.in/ghV_MmrH?, to discover how Allucent’s tailored solutions are supporting our clients at every stage of hematology and hemato-oncology drug development. ? You can also visit us at booth #2653. Our team: Brian Abbott, MD, Vanessa Beddo , Stephanie Dobson Stempf, Rachel Kudgus, Nick Sanich and Trevor Brill-Freund can’t wait to see you there! ? #Allucent #BringNewTherapiesToLight #ClinicalResearch?#ASH24??#Hematology??#hematologyoncology

Allometric scaling is a key tool that allows us to determine first-in-human doses and prepare clinical trial programs for success. Read our blog to learn how Allucent's experts utilize allometric scaling to make predictions about human pharmacokinetics and ultimately inform critical decisions on the drug development journey:?https://lnkd.in/gX-qeXSW. #Allucent #BringNewTherapiesToLight #Pharmacokinetics #ClinicalPharmacology #AllometricScaling